AUG 18, 2026 · JOURNAL ARTICLE
Impact of COVID-19 Vaccination on Patients with Non-Small Cell Lung Cancer Receiving First-Line Immune Checkpoint Inhibitor Therapy: Real-World Evidence from Romania
Medicina
A real observational finding of improved survival with COVID-19 vaccination in advanced NSCLC on immunotherapy, but confounded by unmeasured factors and attenuated to borderline significance in multivariable analysis; requires prospective validation.
Reported
Median PFS (vaccinated vs. unvacc…13.0 vs. 11.0 months
Median OS (vaccinated vs. unvacci…29.0 vs. 24.0 months
p-value (unadjusted PFS and OS)p < 0.001